1. Home
  2. DFIN vs INVA Comparison

DFIN vs INVA Comparison

Compare DFIN & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DFIN
  • INVA
  • Stock Information
  • Founded
  • DFIN 1983
  • INVA 1996
  • Country
  • DFIN United States
  • INVA United States
  • Employees
  • DFIN N/A
  • INVA N/A
  • Industry
  • DFIN Other Consumer Services
  • INVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • DFIN Consumer Discretionary
  • INVA Health Care
  • Exchange
  • DFIN Nasdaq
  • INVA Nasdaq
  • Market Cap
  • DFIN 1.2B
  • INVA 1.1B
  • IPO Year
  • DFIN N/A
  • INVA 2004
  • Fundamental
  • Price
  • DFIN $49.20
  • INVA $21.78
  • Analyst Decision
  • DFIN Strong Buy
  • INVA Buy
  • Analyst Count
  • DFIN 2
  • INVA 5
  • Target Price
  • DFIN $63.50
  • INVA $36.60
  • AVG Volume (30 Days)
  • DFIN 293.5K
  • INVA 938.5K
  • Earning Date
  • DFIN 10-29-2025
  • INVA 11-05-2025
  • Dividend Yield
  • DFIN N/A
  • INVA N/A
  • EPS Growth
  • DFIN N/A
  • INVA 53.96
  • EPS
  • DFIN 1.12
  • INVA 1.52
  • Revenue
  • DFIN $750,800,000.00
  • INVA $388,521,000.00
  • Revenue This Year
  • DFIN N/A
  • INVA $7.98
  • Revenue Next Year
  • DFIN $4.20
  • INVA $11.60
  • P/E Ratio
  • DFIN $43.31
  • INVA $14.24
  • Revenue Growth
  • DFIN N/A
  • INVA 10.14
  • 52 Week Low
  • DFIN $37.80
  • INVA $16.52
  • 52 Week High
  • DFIN $69.93
  • INVA $22.76
  • Technical
  • Relative Strength Index (RSI)
  • DFIN 56.28
  • INVA 66.84
  • Support Level
  • DFIN $44.26
  • INVA $20.68
  • Resistance Level
  • DFIN $47.40
  • INVA $22.48
  • Average True Range (ATR)
  • DFIN 1.23
  • INVA 0.71
  • MACD
  • DFIN 0.61
  • INVA -0.03
  • Stochastic Oscillator
  • DFIN 99.21
  • INVA 57.88

About DFIN Donnelley Financial Solutions Inc.

Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.

About INVA Innoviva Inc.

Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Share on Social Networks: